Trial intelligence / Profile preview

Topical atorvastatin 2% for pain relief and wound healing after hemorrhoidectomy

IRCT201404013014N8Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of atorvastatin in hemorrhoid, sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Post-hemorrhoidectomy pain relief and Wound healing. Started Jul 2014; status: completed.

02

Drugs

atorvastatin
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on IRCT201404013014N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201404013014N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call